💉 TIRZEPATIDE – 10 MG / PEN

Dual Chamber Cartridge – 1.3 ML PEN

Manufacturer: Spectrum PHARMA

🧬 Product Type

Tirzepatide — dual GIP/GLP-1 receptor agonist supplied in a dual-chamber pen cartridge.

🔬 Active Ingredient

Tirzepatide

Strength: 10 MG / Pen

Format: Dual Chamber Cartridge – 1.3 ML Pen

📖 Description

Tirzepatide is a synthetic peptide designed to activate both Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptors.

Through simultaneous activity at these two incretin pathways, tirzepatide influences glucose regulation, insulin secretion, appetite signaling, and gastrointestinal function.

⚙️ Mechanism of Action

Tirzepatide activates GIP and GLP-1 receptors.

This dual receptor activity can:

• Enhance glucose-dependent insulin secretion

• Reduce glucagon secretion when glucose levels are elevated

• Slow gastric emptying

• Influence appetite and food intake

• Improve glucose regulation and insulin sensitivity

⭐ Key Features & Research Applications

• 🧬 Dual GIP + GLP-1 receptor agonist

• 🍽️ Influences appetite and satiety signaling

• 🩸 Supports glucose-dependent insulin regulation

• 🔬 Studied extensively in metabolic and endocrine conditions

• ⚙️ Affects gastric emptying and gastrointestinal signaling

• 💉 Convenient dual-chamber pen presentation

• 🏭 Manufactured by Spectrum PHARMA

⚠️ Possible Side Effects

Commonly reported effects associated with tirzepatide include:

• Nausea

• Vomiting

• Diarrhea

• Constipation

• Abdominal discomfort

• Reduced appetite

• Injection-site reactions

More serious gastrointestinal or metabolic adverse effects may occur in some individuals.

🧊 Storage

Store according to the manufacturer's labeled storage requirements. Temperature and handling requirements may vary before and after activation of the dual-chamber cartridge.

📋 Technical Summary

​